Preferred Label : piperaquine;

MeSH note : differing synonyms provided by different journals;

CISMeF synonym : 1,3-bis(4-(7'-chloro-4'-quinoline)-1-piperazine);

MeSH synonym : 1,3-bis(1-(7-chloro-4'-quinolyl)-4'-piperazinyl)propane; quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-);

MeSH hyponym : quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-, phosphate (1:1); quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-, phosphate (1:4); piperaquine phosphate (1:4) anhydrous; piperaquine tetraphosphate tetrahydrate; quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-, phosphate, hydrate (1:4:4);

MeSH CAS label : quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-);

MeSH Related Number : 4085-31-8 (piperaquine); 5A17BAT3GK; 854D7K8LXB; IHB5WLO51Q;

Registry Number MeSH : 4085-31-8;

Is substance : O;

UNII : A0HV2Q956Y;

InChIKey : UCRHFBCYFMIWHC-UHFFFAOYSA-N;

Details


Main resources

You can consult :


https://www.has-sante.fr/portail/jcms/c_2962279/fr/eurartesim
2019
true
false
France
French
quinolines
artenimol
dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12aR*))-isomer
dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12aR*))-isomer
piperaquine
administration, oral
drug combinations
artenimol and piperaquine
antimalarials
malaria, falciparum
adult
child
infant
artemisinins
treatment outcome
risk management
evaluation of the transparency committee
artemisinins

---
http://www.cochrane.org/fr/CD010927/la-dihydroartemisinine-piperaquine-pour-le-traitement-du-paludisme-non-complique
false
false
false
France
United Kingdom
meta-analysis
french abstract
adult
child
antimalarials
treatment outcome
artemisinins
quinolines
drug therapy, combination
artenimol
malaria
piperaquine

---
http://www.has-sante.fr/portail/jcms/c_1726956/fr/eurartesim
http://www.has-sante.fr/portail/jcms/c_1221619/eurartesim
2014
false
France
French
french guiana
Cardiotoxicity
quinolines
quinolines
artenimol
artenimol
dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12aR*))-isomer
dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12aR*))-isomer
piperaquine
administration, oral
drug combinations
artenimol and piperaquine
antimalarials
malaria, falciparum
adult
child
infant
artemisinins
treatment outcome
controlled clinical trials as topic
antimalarials
artemisinins
piperaquine
risk management
long qt syndrome
pregnancy
product surveillance, postmarketing
evaluation of the transparency committee

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62434676
2013
France
summary of product characteristics
piperaquine
tablets
dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12aR*))-isomer
piperaquine

---
http://www.has-sante.fr/portail/jcms/c_1251592/eurartesim-artenimol-/-piperaquine-antipaludique
2012
France
French
guidelines for drug use
evaluation of the transparency committee
Cardiotoxicity
malaria, falciparum
artenimol and piperaquine
drug combinations
piperaquine
piperaquine
dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12aR*))-isomer
dihydroquinghaosu, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12alpha,12aR*))-isomer
artenimol
artenimol
antimalarials
antimalarials
adult
child
infant
long qt syndrome
aged
treatment outcome
clinical trials, phase iii as topic
quinolines
quinolines
artemisinins
artemisinins
comparative study

---
https://www.ema.europa.eu/medicines/human/EPAR/Eurartesim
2012
United Kingdom
French
English
package leaflet
summary of product characteristics
drug evaluation
syndication feed
artenimol
piperaquine
piperaquine
artenimol
drug combinations
administration, oral
drug approval
treatment outcome
antimalarials
antimalarials
malaria, falciparum
adult
child
infant
artemisinins
artemisinins
quinolines
quinolines
artenimol and piperaquine
aged
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical

---
Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.